title: Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
authors.affiliation: Saint Louis University, Saint Louis, MO, USA.
authors.forename: Zachary S
authors.initials: ZS
authors.lastname: Buchwald
authors.affiliation: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jefstathiou@partners.org.
authors.forename: Jason A
authors.initials: JA
authors.lastname: Efstathiou
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal